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Abstract 
Background and Purpose: Asian American, Native Hawaiian, and Pacific Islander (AANHPI) 
populations may have unique issues (e.g., cultural attitudes and language barriers) that impact their 
relatively low adherence to medication use. Research on the topic is limited because AANHPI 
populations are generally not included in research studies. We conducted a qualitative investigation to 
gain insights into low adherence to medication use among AANHPIs and how to address this health 
disparity. Methods: In-depth individual interviews were conducted with 14 academic pharmacists and 
four other health care professionals knowledgeable about AANHPI disparities. Results: The majority of 
participants were either unsure of appropriate medication use by AANHPIs or felt they were used 
inappropriately. Over half of the participants were involved in or knew of efforts which focused on 
appropriate medication use. Participants felt that approaches to improving medication adherence included 
education and counseling, collaboration between providers, and conducting additional research, a role 
they felt the Daniel K. Inouye College of Pharmacy could fulfill. Conclusion: The appropriate use of 
medications for AANHPI populations is perceived as a barrier to parity in health care by pharmacists and 
other health care professionals. While current efforts exist to address appropriate medication use, 
additional research focusing on potential solutions identified by our participants is required to further 
assess their effectiveness in helping to close the health care gap.  
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Introduction 
 
Asian American, Native Hawaiian, and Pacific 
Islander (AANHPI) populations are growing at 
faster rates than the general population in the 
United States (Census Briefs, 2010). Despite 
documented health care disparities that exist for 
these populations, there continues to be a lack of 
research and knowledge surrounding AANHPIs 
and ways to address disparities. Part of the 
reason for this stems from the fact that studies 
often include very few AANHPIs, making them 
an understudied population (Cook, Grothaus, 
Gutierrez, Kehoe, & Valentin, 2010; Hirano, 
2012).  
 
One area of interest in addressing health care 
disparities is in the area of appropriate 
medication use. In addition to being a major 
cause of serious adverse health events, 
medication non-adherence costs approximately 
$100 billion, and minority populations have 
lower adherence rates than the general 
population in the U.S. (Manias & Williams, 
2010).  Most studies investigating medication 
adherence have focused on persons of European 
descent, and while some studies do include 
minority populations, these generally are 
persons of Black or Latino descent, and 
AANHPI populations are not intentionally 
recruited (Manias & Willams, 2010; Dachs, 
2008). Presently there is a scarcity of published 
trials investigating interventions to improve 
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medication adherence specifically for AANHPI 
populations (Hu, Juarez, Yeboah, & Castillo, 
2015).  
 
Research to date has shown that AANHPI 
populations experience differences in 
medication adherence rates as compared to 
White populations, that cultural expectations and 
attitudes impact medication use, and that 
communication barriers impact appropriate use 
of medications (Dhingra, Lam, & Chen, 2015; 
Hsu, Mao, & Wey, 2010; Hussain-Gambles, 
Leese, Atkin, Brown, Mason, & Tovey, 2004; 
Taira, Gelber, Davis, Gronley, Chung, & Seto, 
2007). For example, medication non-adherence 
has begun to be identified as a barrier to proper 
treatment of cancer-related pain and 
hypertension in Chinese-American patients 
(Dhingra, Lam, & Chen, 2015; Hsu, Mao, & 
Wey, 2010). While quantifiable data are of 
significant importance, qualitative information 
may help to shed light on factors behind these 
barriers to appropriate medication use, 
especially in an area for which there are 
relatively little data.  
 
A 2010 systematic review of ethnic adherence to 
oral hypoglycemic agents noted, “Using results 
of qualitative research that explores patients’ 
perspectives on (medication) adherence in 
specific ethnic groups can lead to a fuller 
understanding” (Peeters, Van Tongelen, 
Boussery, Mehuys, Remon, & Willems, 2010). 
By interviewing pharmacists and health care 
professionals, we hoped to complement research 
on patient perspectives by investigating provider 
perspectives. The perspectives of pharmacists 
regarding medication adherence are of particular 
interest due to the fact that pharmacists are 
uniquely positioned as medication experts in a 
wide variety of practice settings and are easily 
accessible by health professionals and patients, 
and because of the documented impact that 
medication adherence has on patient outcomes. 
 
The Present Study 
We sought to gain knowledge of pharmacists’ 
and other health care professionals’ perspectives 
on how medication adherence impacts health 
care disparities in AANHPI populations. Our 
study surveyed participants with a working 
knowledge of AANHPI populations, who could 
provide insights into factors behind health care 
disparities and suggest methods to address them. 
As noted in our introduction, medication 
adherence is an important and yet understudied 
aspect of care, and thus was a major focus in our 
survey.  
 
Partial results from the study regarding 
participants’ perspectives on other topics have 
been previously published. Those results 
included including factors driving disparities, 
gaps in knowledge, and the roles of the 
University of Hawaii at Hilo Daniel K. Inouye 
College of Pharmacy (DKICP) and U.S. Food 
and Drug Administration (FDA) in reducing 
disparities (Hu, Juarez, Lin, Goo, Yeboah, & 
Castillo, 2015). The results presented in this 
present article have previously been unpublished 
and pertain to pharmacists’ and other health care 
professionals’ perspectives on medication 
adherence and its role in health care disparities 
experienced by AANHPI populations. These 
results are unique and distinct and will be 
discussed separately from previously published 
data.  
 
Methods 
 
Participants  
Semi-structured interviews were conducted face-
to-face when possible, or via telephone or email 
response if the participant was not available for 
a face-to-face interview. The interviews 
generally lasted from thirty to sixty minutes. 
Purposive sampling was used to identify 
fourteen academic pharmacists working in 
Hawaii and ten health professionals on the 
mainland United States. Mainland participants 
were sought in order to capture perspectives 
from Hawaii, which has a unique AANHPI 
population, and the mainland United States, 
where the ethnic landscape differs from Hawaii. 
The academic pharmacists were associated with 
the University of Hawaii at Hilo Daniel K. 
Inouye College of Pharmacy (DKICP) and the 
researchers were aware of their work due to a 
mutual association with the DKICP. The 
mainland participants were from cities with 
large AANHPI populations (Oakland, CA; San 
Francisco, CA; Boston, MA; and New York, 
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NY) and were involved with organizations that 
are active in addressing issues surrounding 
AANHPI health. These mainland participants 
were identified by the U.S. Food and Drug 
Administration’s Office of Minority Health (US 
FDA OMH) and their roles included a director 
of program planning and development, a 
medical director at a diabetes center for Asians, 
a chief medical officer for a community health 
center, and a president of a council for 
physicians. All fourteen pharmacists who were 
approached agreed to be interviewed, and of the 
ten mainland health professionals approached, 
four agreed to be interviewed for a total of 
eighteen participants. All but one interviewee 
consented to being recorded.  
 
Procedures and Measures 
The interviews took place from November 2012 
to February 2013. IRB approval was obtained 
for the study, and participants either gave 
written consent if interviewed in person, or were 
emailed a consent form which stated their 
participation would be accepted as consent. If 
interviewed in person or via telephone, 
participants were asked if their interview could 
be recorded, and the tapes were later transcribed. 
A full list of the interview questions is available 
in a prior publication (Hu, Juarez, Lin, Goo, 
Yeboah, & Castillo, 2015). Interview questions 
related to medication adherence are included 
below:  
 
• Appropriate medication use can be 
described in terms of whether it is 
appropriately prescribed and taken. Do you 
believe that medication is appropriately used 
among Asians and Pacific Islanders?   
• Have you been involved in or do you know 
of any efforts to reduce health disparities 
among Asians and Pacific Islanders that 
focus on appropriate medication use? 
• What do you believe would be the best 
approach to improving appropriate use of 
medications for Asian and Pacific Islander 
sub-groups?  
• How do you feel the College of Pharmacy 
can contribute to reducing disparities in 
appropriate medication use?  
 
 
Analyses 
The tapes from the interviews were then 
transcribed with identifiers removed in order to 
preserve the identities of the participants. The 
transcriptions from the tapes were then analyzed 
line-by-line to identify commonalities in order to 
extract basic categories of responses. Using an 
inductive coding process, sections of text 
relating to these categories were grouped 
together. Two researchers, one of whom had 
been involved in the interview process and one 
who had not been involved, coded responses 
independently in order to reduce errors in coding 
and reveal any discordance in categorization of 
text under the codes (Marks, D.F. & Yardley, L., 
2003).  
 
Results 
 
Participant Characteristics 
The fourteen pharmacists who were interviewed 
ranged in experiences and practice settings, from 
over twenty years of experience to less than five 
years of experience, and career experiences 
included acute medicine, ambulatory care, and 
research-based experiences. Three of the 
mainland health professionals were physicians 
and one worked with NIH based projects as an 
overseer. All four were serving at large 
organizations aimed at improving AANHPI 
health, research, and advocacy.   
 
Appropriate Use of Medications by AANHPI 
Populations 
Seven participants responded that they were 
either unsure or unable to comment on whether 
medications are appropriately used by AANHPI 
populations, or did not directly answer the 
question but rather responded that 
generalizations about medication use were 
difficult to make by race.   
 
Two participants responded by saying “For the 
most part”.  
 
Only one participant responded affirmatively 
when asked if AANHPI populations use 
medications appropriately, but qualified this 
statement by pointing out that there may be a 
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preference for alternative medicines over 
Western medicines. 
Eight participants stated that they did not feel 
that medications are appropriately used. 
Participants felt that factors behind the lack of 
appropriate use of medications included cultural 
attitudes towards medicine, communication 
barriers (lack of English comprehension and 
inadequate provider communication), 
socioeconomic status, and a lack of research for 
AANHPI populations: 
 
Cultural Attitudes Towards Medicine. Four 
participants noted the potential of cultural 
attitudes being a barrier to appropriate 
medication use. Examples given included 
preferences for alternative medicines and a lack 
of understanding of Western medicine. 
 
“Some people want antibiotics 
indiscriminately, many don’t understand 
the need for chronic medication for 
chronic disease, some take drug 
holidays, some believe more in herbal or 
Chinese medicine. Many don’t want 
pain medication, even ibuprofen when it 
can help them. They prefer rubs, 
liniments, Chinese alcohol herb rub and 
physical measures, massage.” 
 
“The medicinal plants that people are 
using from their primary culture, the 
things that they learned growing up 
from their grandparents; that often has 
taken much more time to go through it 
than I would typically be aware of 
otherwise. And my sense is that that 
plays a role in medication adherence, 
sometimes in ways I’ve understood and 
sometimes in ways that have taken me a 
lot longer to understand because I didn’t 
know about the culture. And even the 
use of cultural medicines.” 
“I don’t know that any one is particular 
one is more adherent or not adherent but 
I think it’s largely influenced by their 
culture, by the way they grew up, and 
their diet habits and their activity and 
things like that which are all ingrained 
in us.” 
“Having visited China and realizing the 
way that pharmacy is practiced, the way 
that medicine is practiced there, is that 
the individuals get Eastern and Western 
medicine, herbal medicine. I’m not a big 
believer in herbal medicine given that 
it’s not evidenced based. So, there could 
be some inadequacies if an Asian 
population were to rely solely on that 
type of medication.” 
 
Communication Barriers. Six participants 
noted that communication issues can decrease 
appropriate use of medications both through a 
patient’s inability to comprehend instructions 
and a provider’s inability to communicate 
information to the patient. 
 
“English comprehension and provider 
communication are important. We tend 
to feel rushed. If you talk too fast, locals 
will nod their heads and they won’t 
question you.”  
“Because of the language barrier, the 
medication prescribed is not provided in 
a way they can understand. So they 
would not be compliant to the 
prescription of the medication that needs 
to be taken. They’re told what to take 
but they only understand about half of 
what they’re told, so they don’t take it as 
prescribed because of the language 
barrier.” 
 
Socioeconomic Status. Three participants 
remarked that AANHPI patients often come 
from lower socioeconomic backgrounds and 
may not possess the financial resources 
necessary to access medications. 
 
“You have to be clear. Be mindful of 
patients who are low income and have 
low socioeconomic status…sometimes 
something new comes out, and maybe 
the physician believes that the state or 
the county is going to pay for it, they 
prescribe it out of convenience. 
Sometimes you see patients getting 
medications which aren’t covered by the 
medical insurance they have.” 
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“I think there is definitely inappropriate 
use, and again going back to economics, 
some of it is forced by not being able to 
afford the medication.” 
 
Lack of Research for AANHPI Populations. 
Two participants spoke to a need for increased 
research on AANHPI populations, and felt that 
AANHPIs are understudied in the context of 
medication use. 
 
 “Well, we don’t know. We don’t know 
because there haven’t been good 
tracking systems for Asian Americans. 
If you look at all the government 
sponsored programs, most of them have 
not been including Asian Americans 
specifically. So even [with] large studies 
like NHANES, Asian Americans used to 
not be included. For example, Crestor, 
which is a cholesterol medication, the 
FDA has asked the manufacturer to 
revise the starting dose because of 
differences in hepatic metabolism. But 
who knows, [for] many other drugs, if 
Asian Americans tend to be smaller in 
size, do they still need the same amount 
of medications? If you have a ninety-
pound older Asian woman, is the 
starting medication dose still the same 
as somebody who is a seventy-kilogram 
male? So we don’t know actually, 
whether they’re being appropriately 
prescribed or not. What we know is that 
adherence to medications is a major 
problem in Asian Americans.”  
 
Involvement in/Knowledge of Efforts to 
Reduce Disparities Related to Medication Use 
Two mainland participants and five DKICP 
pharmacist faculty participants stated that they 
either were unsure or unaware of specific current 
efforts to reduce health care disparities for 
AANHPI populations that dealt with medication 
use, or else did not respond in a fashion that 
specifically identified such efforts.  
 
“I’ve not been involved in anything. I 
suspect the college has had outreach 
programs. I really don’t know the extent 
of those programs.” 
 
Eleven respondents identified projects and other 
areas of research aimed at improving appropriate 
medication use for AANHPI populations. A 
DKICP mobile clinic aimed at improving the 
health of Marshallese patients on the island of 
Hawaii was identified by one-third of 
participants (6/18). One participant mentioned 
Pharm2Pharm, a transitions-of-care focused 
effort in Hawaii aimed at facilitating the 
transition from hospital discharge to outpatient 
care.  
 
“Part of the research project that we’re 
doing, the Pacific Island Mobile 
Screening cleaning, is taking pillboxes 
which are currently labeled…we’ve 
translated them into Marshallese, so that 
it’s easier for patients who speak 
Marshallese as their primary language 
so that they understand what the pillbox 
is supposed to do for them. And, then, 
we’ve brought in interpreters to help 
bridge the gap between what they heard 
from the doctor and what they’ve started 
doing with their medication. So, we’ve 
cleared those language gaps.” 
 “I know that our push from 
Pharm2Pharm, the grant that Dr. 
[redacted] received, is aimed towards 
closing the gap in patients that leave the 
hospital and go to the community. I 
don’t think that it’s ethnically based. 
There’s another project that Dr. 
[redacted] is involved with, the 
Marshallese project that goes out to 
rural areas and looks into their 
medication use and safety.” 
 “Some of the work by Papa Ola Lokahi, 
where they tailor patient education 
materials, scenarios to the Native 
Hawaiian population and their cultural 
beliefs, much less translating it in the 
Hawaiian Language. So, I’ve seen that 
of course as far as medication goes and 
some of the education materials in 
written language for immigrants from 
Asia and the Pacific islands.” 
“Hui Ma Lama No Iwi. I believe their 
programs involved helping with 
medication adherence…Their specialty 
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is working with Native Hawaiian 
community members.” 
 
 
Approaches to Improving Medication use for 
AANHPI Populations 
Five of the eighteen participants specifically 
mentioned pharmacist involvement in these 
areas in their responses. Over half (11/18) of 
participants’ answers involved improving 
education and counseling for AANHPI patients, 
a theme that echoed participants’ beliefs that 
language and communication presented barriers 
to appropriate medication use.  
 
“I think there’s a lot that can go into 
that. Health literature itself is difficult 
for standard lay person to understand. 
Providing materials that are translated 
into the different types of languages 
encountered here might be 
helpful…understanding the different 
cultures particularly to a practitioner 
who maybe is new to Hawaii in general 
or isn’t aware of the different types of 
ethnicities here.” 
 “I think that the best approach for 
improving medication use is for when 
they receive their medication that they 
are appropriately counseled by the 
pharmacist or pharmacy staff.” 
“I think one way would be getting more 
health care professionals that have some 
background from that culture and may 
speak the language as well. I think one 
of the biggest barriers is probably 
language. They understand a little bit, 
but they may not fully understand what 
you’re saying. A lot of them rely on 
family members, especially with older 
patients, for help translating. For more 
healthcare professionals who speak 
those languages to help out with their 
medications could be a good thing.” 
 
Three participants spoke to the need for 
improved collaboration between health care 
providers to ensure better care for AANHPI 
patients. 
 
“I would like to see a pharmacist 
associated with every medical clinic in 
Hawaii. Physicians and pharmacists 
working hand in hand…” 
“I think overall it’s going to take a 
concerted effort by the entire health care 
community, not just one individual 
health professional group, everyone has 
to come together and say ‘We want to 
help these people who are maybe not as 
fortunate as other mainstream cultures.” 
 
Four participants believed that the best approach 
to improving appropriate medication use 
required additional research that included these 
AANHPI populations. 
 
“There was a trial being done in the 
Chinese population, and they said, 
“Look, it works for Chinese so it works 
for all Asians!” and the reaction is no, 
we’re Asian but we’re not Chinese. The 
South Asians, we’re considered as 
Asians, but we have different 
pathophysiology. So that is what, we 
need to do more trials and more research 
at the level of diversity of our 
population and do be more effective…. 
so that is what is lacking, research and 
trials within our own population. 
Understanding and recognizing that 
Asians are very diverse.” 
 “Well I would advocate testing the 
drugs in different populations, I think 
that’s important, especially for efficacy 
and side effects. I mean that’s step 
number one, to establish the right dose 
and ethnic specific side effect profile. 
And two, is for some of the ethnic 
minorities among Asian Americans, 
having drug information available in 
major languages can improve their 
care...you can imagine a lot of these 
people go to the pharmacy and they 
don’t have information in their own 
language, and that’s not very helpful.” 
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College of Pharmacy Contributions to 
Reducing Disparities in Appropriate 
Medication Use 
The fourteen participants from Hawaii were 
asked what role they felt the DKICP could play 
in reducing health care disparities. Four common 
categories of responses were identified: the 
education of pharmacy students, the 
advancement of research, involvement in 
community projects, and faculty clinical 
practice.  
 
Education of Pharmacy Students. Seven 
participants spoke to the education of pharmacy 
students as a strength of the DKICP and its role 
in improving appropriate medication use. 
Through its unique location in Hawaii, where 
there is a large and diverse AANHPI population, 
students are exposed to many cultures and learn 
cultural sensitivity, a vital aspect to helping 
patients adhere to their medications.  
 
“We try to influence our students to be 
culturally aware. Try to influence our 
students that the pharmacist does more 
than lick, stick, count and pour. That the 
more important aspects of practice of 
pharmacy is patient focused care.” 
“I think teaching students about the 
cultures, about factors that they may 
need to be aware of as they go on 
rotations is very beneficial, because just 
having an awareness of it, can make a 
difference. Not assuming that every 
patient is your cookie cutter, white 
majority patient.” 
 
Advancement of Research. Six participants’ 
responses focused on opportunities for the 
DKICP to contribute to increased research with 
AANHPI populations and medication adherence.  
 
“I think on the larger scope of things we 
probably need to be funded through 
grants to specifically target these 
populations. Specifically, do targeted 
interventions for these populations to 
improve their adherence and their 
education and their health literacy. I 
know Pharm2Pharm is doing some of 
that in the community.” 
One participant noted that the DKICP is 
located in an area with a large 
population AANHPI patient population, 
thus poising it to expand on research:  
“I think that the College of Pharmacy 
almost the perfect lab to contribute to 
the evidence in this area because where 
we’re located. It’s almost a natural, not 
only on the Big Island, but throughout 
Hawaii like the other Asian and Pacific 
Islander groups that might be more 
prevalent.” 
 
Involvement in Community Projects. Five 
participants mentioned DKICP involvement in 
community outreach projects as an aspect of its 
role in improving medication adherence.  
 
“I think that our college of pharmacy is 
on the right track. We have a lot of 
health fairs. We go out to rural 
populations. We encourage people to 
attend our health fairs, and we train our 
students to really spend time with 
people.” 
 
Faculty Clinical Practice. The contributions of 
DKICP faculty in clinical practice sites were 
mentioned by five participants. 
 
“I think it’s definitely a part of this 
College of Pharmacy’s mission to be 
investigating both healthcare disparities 
and medication adherence in ways that 
which can improve in our community 
which is Hilo to the entire state and 
possibly the Pacific. I think that this 
state is way behind in the practice of 
pharmacy anyway, so we have a lot of 
change in the [College] to bring 
pharmacy practice up to the current 
standards, but also the human challenges 
we have with a diverse population and a 
rural population.” 
“We’re putting faculty members and 
staff at sites that need additional help to 
improve patient care. Obviously our 
students are helping in that process too, 
on rotations.” 
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Discussion 
 
Participants generally felt that medications are 
not used appropriately by AANHPI populations. 
When asked whether they thought medications 
were used appropriately, all but three of our 
participants responded negatively or with 
uncertainty. Participants’ responses regarding 
factors behind the lack appropriate use of 
medications broadly fell into four categories: 
cultural attitudes towards medicine, 
communication barriers (lack of English 
comprehension and inadequate provider 
communication), socioeconomic status, and a 
lack of research for AANHPI populations. 
Participants’ responses broadly fell into three 
categories when asked what they felt would be 
the best approach to improving medication 
adherence for AANHPIs: education and 
counseling, collaboration between providers, 
and additional research. 
 
Cultural Attitudes, Communication Barriers, 
and Socioeconomic Status 
The identification of cultural attitudes, 
socioeconomic status, and communication as 
barriers to appropriate medication use by our 
participants echoes findings in the literature. 
Cultural attitudes and communication barriers 
have been identified as factors affecting 
medication adherence in Chinese populations, 
and overall health improvement for Filipinos 
(Hsu, Mao, & Wey, 2010; Li, Stewart, Stotts, & 
Froelicher, 2006; Pobutsky, Cuaresma, Kishaba, 
Noble, Leung, & Villaguerte, 2015).  
 
Other studies and publications discuss the fact 
that communication and language barriers create 
hindrances in appropriate medication use for 
these populations (Dhingra, Lam, & Chen, 2015; 
Hussain-Gambles, Leese, Atkin, Brown, Mason, 
& Tovey, 2004; Li, Stewart, Stotts, & 
Froelicher, 2006).  
 
A 2008 survey by Kaholokula and colleagues 
investigated the perspectives of Pacific Islander 
patients and revealed that patients felt that 
patient-provider communication created a 
barrier to their care and their understanding of 
medications’ side effects (Kaholokula, Saito, 
Mau, Latimer, & Seto, 2008). The perspectives 
of the pharmacists and health care professionals 
who we surveyed provide an interesting 
counterpoint to patient perspectives and 
demonstrate a mutual acknowledgement of the 
importance of patient-provider communication 
in improving knowledge of medications for 
AANHPI populations. Over half of participants 
remarked on pharmacist involvement as an area 
of opportunity in addressing the need for 
education and counseling of AANHPI patients. 
 
While socioeconomic status impacts access to 
health care and medications, its impact on 
medication adherence is less well-established. Li 
and colleagues contend that the literature does 
not suggest socioeconomic status is predictive of 
medication adherence. Juarez and colleagues 
conducted a retrospective analysis of claims data 
to investigate potential medication adherence 
disparities for AANHPI persons in Hawaii but 
were unable to adjust for socioeconomic status. 
Further research will likely be needed in this 
area to more fully elucidate the impact of 
socioeconomic status on medication adherence 
in AANHPI populations (Isaacs & Schroeder, 
2004; Juarez, Davis, Tan, & Mau, 2014; Li, 
Stewarts, Stotts, & Froelicher, 2006; Li, Stotts, 
& Froelicher, 2007).  
 
Lack of Research 
Participants remarked on the fact that 
medications may not be appropriately used in 
AANHPI populations because of potentially 
inappropriate dosing and prescribing due to the 
lack of research with these populations. A 2007 
article published by Li noted that a search of the 
literature from 1966-2005 found no studies 
which discussed the influence of Chinese culture 
and/or medicine on medication compliance in 
Chinese populations (Li, Stotts, & Froelicher, 
2007). A more recent editorial by Ro and Yee 
called for more research to be done and stated, 
“There is a scarcity of basic health research on 
Asian Americans, Native Hawaiians, and Pacific 
Islanders. The data and research available for 
Native Hawaiians and Pacific Islanders is almost 
nonexistent” (Ro & Yee, 2010). 
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Current Efforts to Address Medication 
Adherence and the Role of the DKICP 
Mainland and Hawaii participants both 
referenced their own clinical practice sites when 
asked to cite any knowledge of current efforts to 
address medication adherence. The participants 
from Hawaii provided insights into the role of 
the DKICP in addressing medication adherence. 
The fact that a need for additional research in 
these populations was highlighted by several 
participants dovetailed with their beliefs that the 
DKICP could further research focused on 
AANHPI populations. The most commonly 
identified project by Hawaii participants was a 
DKICP initiative using a mobile clinic aimed at 
helping Marshallese patients, and one 
respondent mentioned Pharm2Pharm. While 
Pharm2Pharm helps AANHPI patients, its goals 
are broader in that it aims to serve all patients in 
Hawaii (Pellegrin, 2015). In addition to the 
mobile clinic and Pharm2Pharm, the DKICP 
positions pharmacists to work in hospitals and 
clinics on multiple islands across the state of 
Hawaii, and combined with ongoing research 
from DKICP faculty and associates, these efforts 
can position the DKICP to be a contributor to 
minority health by improving medication 
adherence (Juarez, Tan, Davis, & Mau, 2014; 
Pezzuto & Ma, 2015). 
 
Limitations 
There are some limitations in this study. As only 
one interviewer conducted the interviews, 
research quality may be influenced by the 
researcher's personal biases. We attempted to 
lessen any impact by transcribing the data and 
having another researcher independently code 
and compare results. Moreover, as our 
interviews were primarily focused on health care 
professionals, further research is needed to gain 
an understanding of the patient perspective of 
the role of pharmacists, pharmacy schools, and 
the FDA in improving the health of vulnerable 
populations. 
 
Conclusion 
 
The responses given by our participants show 
that both mainland health care professionals and 
pharmacists in Hawaii believe that making 
improvements in the appropriate use of 
medications can be a way to improve health care 
for AANHPI populations. This work provides a 
description of their insights into the impact that 
medication adherence may have on health care 
disparities for AANHPI populations, as well as 
what roles pharmacists in Hawaii and the 
DKICP can play in addressing appropriate 
medication use for these patients. These 
perspectives highlight the need for pharmacists 
and other health professionals to have cultural 
competency when addressing the needs of 
AANHPI populations, and the importance of 
instilling this concept as a value early on in the 
education of future health care professionals. 
Enhancing our knowledge and understanding of 
the needs of AANHPI populations will help to 
guide future research and efforts to reduce 
healthcare disparities caused by inappropriate 
medication. Continued qualitative research will 
help to reveal insights into the needs of 
AANHPI populations and methods to address 
medication adherence issues. 
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